Europe Over-the-Counter Drugs Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Over-the-Counter Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Over-the-Counter Drugs Market Segmentations:

    By Player:

    • Glenmark Pharmaceuticals

    • Merck

    • Novartis

    • GlaxoSmithKline

    • Sanofi

    • Bayer

    • Sun Pharmaceutical Industries

    • Alkem Laboratories

    • Boehringer Ingelheim

    • Teva Pharmaceutical Industries

    • Johnson & Johnson

    • Pfizer

    • Cipla

    By Type:

    • Analgesics & Pain Relievers

    • Cough, Cold and Flu Products

    • Dermatological Products

    • Vitamin & Mineral Supplements

    • Gastrointestinal Products

    • Sleep Aids

    • Weight Loss Products

    • Smoking Cession Aids

    • Ophthalmic Products

    • Others

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Over-the-Counter Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Over-the-Counter Drugs Market Size and Growth Rate of Analgesics & Pain Relievers from 2014 to 2026

    • 1.3.2 Europe Over-the-Counter Drugs Market Size and Growth Rate of Cough, Cold and Flu Products from 2014 to 2026

    • 1.3.3 Europe Over-the-Counter Drugs Market Size and Growth Rate of Dermatological Products from 2014 to 2026

    • 1.3.4 Europe Over-the-Counter Drugs Market Size and Growth Rate of Vitamin & Mineral Supplements from 2014 to 2026

    • 1.3.5 Europe Over-the-Counter Drugs Market Size and Growth Rate of Gastrointestinal Products from 2014 to 2026

    • 1.3.6 Europe Over-the-Counter Drugs Market Size and Growth Rate of Sleep Aids from 2014 to 2026

    • 1.3.7 Europe Over-the-Counter Drugs Market Size and Growth Rate of Weight Loss Products from 2014 to 2026

    • 1.3.8 Europe Over-the-Counter Drugs Market Size and Growth Rate of Smoking Cession Aids from 2014 to 2026

    • 1.3.9 Europe Over-the-Counter Drugs Market Size and Growth Rate of Ophthalmic Products from 2014 to 2026

    • 1.3.10 Europe Over-the-Counter Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Over-the-Counter Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • 1.4.2 Europe Over-the-Counter Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.3 Europe Over-the-Counter Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Over-the-Counter Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Over-the-Counter Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Analgesics & Pain Relievers

      • 3.4.2 Market Size and Growth Rate of Cough, Cold and Flu Products

      • 3.4.3 Market Size and Growth Rate of Dermatological Products

      • 3.4.4 Market Size and Growth Rate of Vitamin & Mineral Supplements

      • 3.4.5 Market Size and Growth Rate of Gastrointestinal Products

      • 3.4.6 Market Size and Growth Rate of Sleep Aids

      • 3.4.7 Market Size and Growth Rate of Weight Loss Products

      • 3.4.8 Market Size and Growth Rate of Smoking Cession Aids

      • 3.4.9 Market Size and Growth Rate of Ophthalmic Products

      • 3.4.10 Market Size and Growth Rate of Others

    4 Segmentation of Over-the-Counter Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Over-the-Counter Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Hospital Pharmacies for Construction

      • 4.4.2 Market Size and Growth Rate of Retail Pharmacies for Construction

      • 4.4.3 Market Size and Growth Rate of Online Pharmacies for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Over-the-Counter Drugs Production Analysis by Top Regions

    • 5.2 Europe Over-the-Counter Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Over-the-Counter Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Over-the-Counter Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Over-the-Counter Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Over-the-Counter Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Over-the-Counter Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Over-the-Counter Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Over-the-Counter Drugs Landscape Analysis

    • 7.1 Germany Over-the-Counter Drugs Landscape Analysis by Major Types

    • 7.2 Germany Over-the-Counter Drugs Landscape Analysis by Major End-Users

    8. UK Over-the-Counter Drugs Landscape Analysis

    • 8.1 UK Over-the-Counter Drugs Landscape Analysis by Major Types

    • 8.2 UK Over-the-Counter Drugs Landscape Analysis by Major End-Users

    9. France Over-the-Counter Drugs Landscape Analysis

    • 9.1 France Over-the-Counter Drugs Landscape Analysis by Major Types

    • 9.2 France Over-the-Counter Drugs Landscape Analysis by Major End-Users

    10. Italy Over-the-Counter Drugs Landscape Analysis

    • 10.1 Italy Over-the-Counter Drugs Landscape Analysis by Major Types

    • 10.2 Italy Over-the-Counter Drugs Landscape Analysis by Major End-Users

    11. Spain Over-the-Counter Drugs Landscape Analysis

    • 11.1 Spain Over-the-Counter Drugs Landscape Analysis by Major Types

    • 11.2 Spain Over-the-Counter Drugs Landscape Analysis by Major End-Users

    12. Poland Over-the-Counter Drugs Landscape Analysis

    • 12.1 Poland Over-the-Counter Drugs Landscape Analysis by Major Types

    • 12.2 Poland Over-the-Counter Drugs Landscape Analysis by Major End-Users

    13. Russia Over-the-Counter Drugs Landscape Analysis

    • 13.1 Russia Over-the-Counter Drugs Landscape Analysis by Major Types

    • 13.2 Russia Over-the-Counter Drugs Landscape Analysis by Major End-Users

    14. Switzerland Over-the-Counter Drugs Landscape Analysis

    • 14.1 Switzerland Over-the-Counter Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Over-the-Counter Drugs Landscape Analysis by Major End-Users

    15. Turkey Over-the-Counter Drugs Landscape Analysis

    • 15.1 Turkey Over-the-Counter Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Over-the-Counter Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Over-the-Counter Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Over-the-Counter Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Over-the-Counter Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Over-the-Counter Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Over-the-Counter Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Over-the-Counter Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Over-the-Counter Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Over-the-Counter Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Over-the-Counter Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Over-the-Counter Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Over-the-Counter Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Glenmark Pharmaceuticals

      • 19.1.1 Glenmark Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Merck

      • 19.2.1 Merck Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Novartis

      • 19.3.1 Novartis Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 GlaxoSmithKline

      • 19.4.1 GlaxoSmithKline Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Sanofi

      • 19.5.1 Sanofi Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Bayer

      • 19.6.1 Bayer Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Sun Pharmaceutical Industries

      • 19.7.1 Sun Pharmaceutical Industries Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Alkem Laboratories

      • 19.8.1 Alkem Laboratories Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Boehringer Ingelheim

      • 19.9.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Teva Pharmaceutical Industries

      • 19.10.1 Teva Pharmaceutical Industries Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Johnson & Johnson

      • 19.11.1 Johnson & Johnson Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Pfizer

      • 19.12.1 Pfizer Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Cipla

      • 19.13.1 Cipla Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    The List of Tables and Figures (Totals 117 Figures and 130 Tables)

    • Figure Product Picture

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Analgesics & Pain Relievers Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Cough, Cold and Flu Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Dermatological Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Vitamin & Mineral Supplements Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Gastrointestinal Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Sleep Aids Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Weight Loss Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Smoking Cession Aids Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Ophthalmic Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Germany Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Over-the-Counter Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Over-the-Counter Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Over-the-Counter Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Over-the-Counter Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Over-the-Counter Drugs by Different Types from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Analgesics & Pain Relievers Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Cough, Cold and Flu Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Dermatological Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Vitamin & Mineral Supplements Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Gastrointestinal Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Sleep Aids Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Weight Loss Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Smoking Cession Aids Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Ophthalmic Products Market, 2015 - 2026 (USD Million)

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Others Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Over-the-Counter Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Over-the-Counter Drugs by Different End-Users from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Hospital Pharmacies from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Over-the-Counter Drugs Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Table Europe Over-the-Counter Drugs Production by Major Regions

    • Table Europe Over-the-Counter Drugs Production Share by Major Regions

    • Figure Europe Over-the-Counter Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Over-the-Counter Drugs Consumption by Major Regions

    • Table Europe Over-the-Counter Drugs Consumption Share by Major Regions

    • Table Germany Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table UK Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table France Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Over-the-Counter Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Germany Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table UK Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table France Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table France Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table France Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Italy Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Spain Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Poland Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Russia Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Over-the-Counter Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Over-the-Counter Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Over-the-Counter Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Over-the-Counter Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Glenmark Pharmaceuticals Profiles

    • Table Glenmark Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Glenmark Pharmaceuticals Product benchmarking

    • Table Glenmark Pharmaceuticals Strategic initiatives

    • Table Glenmark Pharmaceuticals SWOT analysis

    • Table Merck Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Merck Product benchmarking

    • Table Merck Strategic initiatives

    • Table Merck SWOT analysis

    • Table Novartis Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis Product benchmarking

    • Table Novartis Strategic initiatives

    • Table Novartis SWOT analysis

    • Table GlaxoSmithKline Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table GlaxoSmithKline Product benchmarking

    • Table GlaxoSmithKline Strategic initiatives

    • Table GlaxoSmithKline SWOT analysis

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Bayer Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Bayer Product benchmarking

    • Table Bayer Strategic initiatives

    • Table Bayer SWOT analysis

    • Table Sun Pharmaceutical Industries Profiles

    • Table Sun Pharmaceutical Industries Production, Value, Price, Gross Margin 2014-2019

    • Table Sun Pharmaceutical Industries Product benchmarking

    • Table Sun Pharmaceutical Industries Strategic initiatives

    • Table Sun Pharmaceutical Industries SWOT analysis

    • Table Alkem Laboratories Profiles

    • Table Alkem Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Alkem Laboratories Product benchmarking

    • Table Alkem Laboratories Strategic initiatives

    • Table Alkem Laboratories SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Teva Pharmaceutical Industries Profiles

    • Table Teva Pharmaceutical Industries Production, Value, Price, Gross Margin 2014-2019

    • Table Teva Pharmaceutical Industries Product benchmarking

    • Table Teva Pharmaceutical Industries Strategic initiatives

    • Table Teva Pharmaceutical Industries SWOT analysis

    • Table Johnson & Johnson Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Johnson & Johnson Product benchmarking

    • Table Johnson & Johnson Strategic initiatives

    • Table Johnson & Johnson SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Cipla Profiles

    • Table Cipla Production, Value, Price, Gross Margin 2014-2019

    • Table Cipla Product benchmarking

    • Table Cipla Strategic initiatives

    • Table Cipla SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.